Search results for "Congresses as Topic"

showing 10 items of 27 documents

CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy

2018

ABSTRACT The 16th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s largest meeting series of its kind, took place in Mainz, Germany from 15–17 May, 2018. Cutting-edge advancements in cancer immunotherapy were discussed among more than 700 scientists under the motto “Pushing Frontiers in Cancer Immunotherapy”. This meeting report is a summary of some of the CIMT 2018 highlights.

0301 basic medicineOncologymedicine.medical_specialtyCombination therapymedicine.medical_treatmentImmunologyMeeting Reportcombination therapyCell therapy03 medical and health sciencesCancer immunotherapyInternal medicineNeoplasmsmedicineTumor MicroenvironmentImmunology and AllergyAnimalsHumansPersonalized therapytumor vaccinationPharmacologypersonalized therapyTumor microenvironmentcancer immunotherapybusiness.industryVaccinationCIMTcellular therapyCongresses as TopicXenograft Model Antitumor AssaysDisease Models Animal030104 developmental biologycheckpoint blockadeDrug Therapy CombinationImmunotherapybusinessHuman Vaccines & Immunotherapeutics
researchProduct

Bordeaux 2018: Wine, Cheese, and γδ T Cells

2019

The first ‘International γδ T cell conference’ took place in Denver, CO (USA) in 2004. Since then, a new meeting is held every two years. During each conference, all participants voted to choose between candidate bids for where to hold the next conference. At the conference held in London in 2016, a majority opted for the bid from a team proposing the 2018 event be held in Bordeaux, France – which is where we therefore gathered on 7-10th of June 2018. The meeting was an undisputed success and it gave us the opportunity to take stock of the increasing basic knowledge about γδ T cells as well as the rapidly expanding interest and activities developing using γδ T cells towards clinical applica…

0301 basic medicinelcsh:Immunologic diseases. AllergyOpinionrecent advancesT cellImmunologyReceptors Lymphocyte HomingLibrary scienceInfectionsLymphocyte Activation03 medical and health sciences0302 clinical medicineBasic knowledgeongoing researchT-Lymphocyte SubsetsPolitical scienceNeoplasmsmedicineImmunology and AllergyAnimalsHumansgamma delta T cellsInflammationButyrophilinsReceptors Antigen T-Cell gamma-deltaCongresses as Topicfutures perspectives030104 developmental biologymedicine.anatomical_structureconference reportImmunotherapylcsh:RC581-607030215 immunologyFrontiers in Immunology
researchProduct

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

2019

Background Six months of adjuvant oxaliplatin-based chemotherapy is standard for patients with stage III colon cancer following surgery. However, oxaliplatin is associated with peripheral neurotoxicity which worsens over treatment duration. Consequently, a shorter treatment duration, if equally effective, would be extremely beneficial. A pooled analysis of data for 12 834 stage III colon cancer patients, from six randomised phase III trials of adjuvant therapy, the International Duration Evaluation of Adjuvant chemotherapy study, was carried out and the results presented at the ASCO Annual Meeting 2017. To clarify the potential impact of these results on clinical practice, ESMO decided to s…

0301 basic medicinemedicine.medical_specialtyTime FactorsColorectal cancerRisk AssessmentDisease-Free Survival03 medical and health sciences0302 clinical medicineFOLFOXInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineAdjuvant therapyHumansMulticenter Studies as TopicColectomyNeoplasm StagingRandomized Controlled Trials as Topicbusiness.industryCAPOX RegimenHematologyCongresses as Topicmedicine.diseaseChemotherapy regimenOxaliplatinClinical trialOxaliplatinRegimen030104 developmental biologyOncologyClinical Trials Phase III as TopicChemotherapy Adjuvant030220 oncology & carcinogenesisData Interpretation StatisticalColonic NeoplasmsPractice Guidelines as TopicQuality of LifeNeurotoxicity Syndromesbusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

In Vivo Reprogramming for Brain and Spinal Cord Repair.

2015

AbstractCell reprogramming technologies have enabled the generation of various specific cell types including neurons from readily accessible patient cells, such as skin fibroblasts, providing an intriguing novel cell source for autologous cell transplantation. However, cell transplantation faces several difficult hurdles such as cell production and purification, long-term survival, and functional integration after transplantation. Recently,in vivoreprogramming, which makes use of endogenous cells for regeneration purpose, emerged as a new approach to circumvent cell transplantation. There has been evidence forin vivoreprogramming in the mouse pancreas, heart, and brain and spinal cord with …

7NeurogenesisCellReviewBiologyNovel Tools and Methods03 medical and health sciences0302 clinical medicineastrocytemedicineAnimalsHumansCellular Reprogramming Techniques030304 developmental biologyNeurons0303 health sciencesCellular Reprogramming TechniquesGeneral NeuroscienceRegeneration (biology)brain repairNeurogenesisBrainreprogrammingGeneral MedicineCongresses as TopicCellular ReprogrammingneuronNerve RegenerationTransplantationin vivomedicine.anatomical_structureSpinal CordDistrict of ColumbiaNG2 cellNeuronReprogrammingNeuroscience030217 neurology & neurosurgeryAstrocyteeNeuro
researchProduct

Making the most of scientific medical conferences: a practical guide for students and junior trainees.

2019

AdultMaleMedical educationMedical staffStudents Medicalbusiness.industryGastroenterologyMEDLINECongresses as TopicYoung AdultMedical Staff HospitalMedicineHumansFemalebusinessColorectal SurgeryColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
researchProduct

Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Soreze 2009

2010

Background: Inherited ichthyoses belong to a large, clinically and etiologically heterogeneous group of mendelian disorders of cornification; typically involving the entire integument. Over the recent years, much progress has been made defining their molecular causes. However, there is no internationally accepted classification and terminology. Objective: We sought to establish a consensus for the nomenclature and classification of inherited ichthyoses. Methods: The classification project started at the First World Conference on Ichthyosis in 2007. A large international network of expert clinicians, skin pathologists, and geneticists entertained an interactive dialogue over 2 years, eventua…

AdultMalemedicine.medical_specialtyCongenital ichthyosiform erythrodermaAdolescentautosomal recessive congenital ichthyosisDermatologySeverity of Illness Indexhistologymendelian disorders of cornificationYoung AdultCYP4F22Terminology as TopicCongenital ichthyosisMedicineHumansGenetic Predisposition to DiseasegeneticsABCA12Childbiologybusiness.industryIchthyosisInfant NewbornIchthyosisInfantkeratinopathic ichthyosisLamellar ichthyosisHarlequin IchthyosisCongresses as TopicIchthyosiform Erythroderma Congenitalepidermolytic ichthyosismedicine.diseasePrognosisDermatologyultrastructureGene Expression RegulationPractice Guidelines as Topicbiology.proteinFemaleDermatologic AgentsFrancesuperficial epidermolytic ichthyosisbusinessIchthyosis vulgarisJournal of the American Academy of Dermatology
researchProduct

iGEM 2.0—refoundations for engineering biology

2014

Biomedical EngineeringMEDLINEHumansMolecular MedicineSynthetic BiologyBioengineeringEngineering ethicsCongresses as TopicBiologyStudentsApplied Microbiology and BiotechnologyBiotechnologyNature Biotechnology
researchProduct

PsychDT Working Group

2015

Background: Diabetes technology is a cornerstone of diabetes management in the 21st century, with advances in available devices over recent years playing a central role in the way that health care has progressed. Psychosocial interventions have been shown to have a positive impact on glycemic control, reduce psychological distress and reduce costs of health care. Addressing and improving psychosocial outcomes that complement biomedical improvements and looking to the future are crucial to enhance patient acceptance of artificial pancreas (AP) systems. Methods: To achieve closer collaboration and comparability across different AP research trials, a working group was established. Results: Exi…

Blood GlucosePancreas ArtificialGerontologyParisEndocrinology Diabetes and MetabolismDecision MakingBiomedical EngineeringBioengineeringArtificial pancreasAutomationQuality of life (healthcare)Diabetes managementDiabetes mellitusHealth careInternal MedicineHumansPsychologyMedicineInterdisciplinary communicationClinical Trials as Topicbusiness.industryManagement scienceProceedings of Meetings/ConferencesCornerstoneCongresses as Topicmedicine.diseaseDiabetes Mellitus Type 1Quality of LifeInterdisciplinary CommunicationbusinessPsychosocialJournal of Diabetes Science and Technology
researchProduct

The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of chronic venous disease.

2017

Despite continuous improvement in our knowledge and management of chronic venous disease (CVD), certain areas, such as the role of muscarinic receptors in the pathology and treatment of CVD, remain unexplored. The symposium "The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of CVD", held at the Annual Meeting of the European Venous Forum on 7-9 July 2016 in London, presented an update on the pathophysiology of CVD and highlighted how the combination of Ruscus extract, hesperidin methyl chalcone, and vitamin C (Ruscus/HMC/VitC; Cyclo 3® Fort), may counteract the deleterious processes underlying CVD. The data presented during this symposium are reported …

ChalconeInflammationAscorbic Acid030204 cardiovascular system & hematologyPharmacologyVeins03 medical and health scienceschemistry.chemical_compoundHesperidin0302 clinical medicineChalconesLondonMedicineHumansVascular DiseasesRandomized Controlled Trials as TopicbiologyVitamin Cbusiness.industryPlant ExtractsHesperidinCongresses as Topicbiology.organism_classificationResponse to treatmentPathophysiologyRuscusTreatment OutcomechemistryRuscus030220 oncology & carcinogenesisChronic DiseaseDrug Therapy Combinationmedicine.symptomCardiology and Cardiovascular MedicineVenous diseasebusinessPhytotherapyInternational angiology : a journal of the International Union of Angiology
researchProduct

Predatory journals and conferences: why fake counts

2020

Purpose of review Predatory publishing poses a serious educational end ethical threat to the credibility of science. The aim of this review is to discuss the main features of this deceptive open-access model, its potential consequences and relevance for the whole scientific community. Recent findings Recent reports showed that scholars and clinicians from all research fields, including anesthesiology, are facing an alarming invasion of predatory journals and, more recently, fake conferences. This review discusses key elements of these phenomena and proposes countermeasures to tackle the problem. Summary Predatory journals and conferences are two sides of the same coin. As here reviewed, the…

Deceptionmedia_common.quotation_subjectMEDLINE03 medical and health sciences0302 clinical medicinePredatory publishingAnesthesiologyCredibilityHumansRelevance (law)Medicine030212 general & internal medicineCurriculummedia_commonPublishingbusiness.industryPublic relationsDeceptionCongresses as TopicClinical PracticeAnesthesiology and Pain MedicinePublishingPeriodicals as Topicbusiness030217 neurology & neurosurgeryHuman
researchProduct